1-3 of 3
Ryosuke Kita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MDS and MDS/MPN Genomic Subgroups Demonstrate Differential E x Vivo Drug Sensitivity

Michael A Spinner, Steven A Schaffert, Henning Stehr, Marianne T Santaguida, Ryosuke Kita, Alexey Aleshin, James L Zehnder, Peter L. Greenberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 4645.
https://doi.org/10.1182/blood-2021-152103
Published: 2021
Journal Articles

Prediction of Clinical Response to Venetoclax Plus Decitabine in AML Using a 7-Day Ex Vivo Assay

Markus D Lacher, Michelle A Richardson, Steven A Schaffert, Ryosuke Kita, Marianne T Santaguida, Erica K Anderson, Jordan Roselli, Wade Anderson, Arisa Paul, Christine Gu, Kathryn Vanderlaag, Zhihong Zeng, Abhishek Maiti, Courtney D. DiNardo, Marina Konopleva
Journal: Blood
Blood (2021) 138 (Supplement 1): 3464.
https://doi.org/10.1182/blood-2021-148891
Published: 2021
Journal Articles

Ex Vivo Drug Sensitivity Assay Correlates with Clinical Response and Identifies Panobinostat and Bortezomib As a Potential Novel Drug Combination for Pediatric AML

Debbie C Strachan, Christine Gu, Ryosuke Kita, Michelle A Richardson, Erica K Anderson, Alan K Gonzalez, Noah J Keogh, Hailey H Oviedo, Michelle C Alozie, Raushan Rashid, Maci Terrell, Andrea N Marcogliese, Marianne T Santaguida, Alexandra McLean Stevens
Journal: Blood
Blood (2021) 138 (Supplement 1): 2361.
https://doi.org/10.1182/blood-2021-145275
Published: 2021